DK475389D0 - Fremgangsmaade til reduktion af monoklonale antistoffers heterogenitet - Google Patents
Fremgangsmaade til reduktion af monoklonale antistoffers heterogenitetInfo
- Publication number
- DK475389D0 DK475389D0 DK475389A DK475389A DK475389D0 DK 475389 D0 DK475389 D0 DK 475389D0 DK 475389 A DK475389 A DK 475389A DK 475389 A DK475389 A DK 475389A DK 475389 D0 DK475389 D0 DK 475389D0
- Authority
- DK
- Denmark
- Prior art keywords
- monoclonal antibodies
- reducing heterogeneity
- heterogeneity
- reducing
- monoclonal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25078888A | 1988-09-28 | 1988-09-28 | |
| US25078688A | 1988-09-28 | 1988-09-28 | |
| US25078788A | 1988-09-28 | 1988-09-28 | |
| US07/364,056 US5126250A (en) | 1988-09-28 | 1989-06-09 | Method for the reduction of heterogeneity of monoclonal antibodies |
| CA000613379A CA1332367C (en) | 1988-09-28 | 1989-09-26 | Method for the reduction of heterogeneity of monoclonal antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK475389D0 true DK475389D0 (da) | 1989-09-27 |
| DK475389A DK475389A (da) | 1990-03-29 |
Family
ID=27508376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK475389A DK475389A (da) | 1988-09-28 | 1989-09-27 | Fremgangsmaade til reduktion af monoklonale antistoffers heterogenitet |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0361902B1 (da) |
| JP (1) | JP2925181B2 (da) |
| CN (1) | CN1041392A (da) |
| AR (1) | AR242986A1 (da) |
| AT (1) | ATE101876T1 (da) |
| AU (1) | AU615576B2 (da) |
| BG (1) | BG60017B2 (da) |
| CA (1) | CA1332367C (da) |
| DE (1) | DE68913251T2 (da) |
| DK (1) | DK475389A (da) |
| ES (1) | ES2049332T3 (da) |
| IE (1) | IE63562B1 (da) |
| IL (1) | IL91778A (da) |
| MX (1) | MX170441B (da) |
| NZ (1) | NZ230786A (da) |
| PL (1) | PL162260B1 (da) |
| RO (1) | RO105652B1 (da) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104761637B (zh) | 2006-03-31 | 2021-10-15 | 中外制药株式会社 | 调控抗体血液动力学的方法 |
| EP1878747A1 (en) | 2006-07-11 | 2008-01-16 | greenovation Biotech GmbH | Glyco-engineered antibodies |
| EP2031064A1 (de) * | 2007-08-29 | 2009-03-04 | Boehringer Ingelheim Pharma GmbH & Co. KG | Verfahren zur Steigerung von Proteintitern |
| CN101874042B9 (zh) | 2007-09-26 | 2019-01-01 | 中外制药株式会社 | 利用cdr的氨基酸取代来改变抗体等电点的方法 |
| EP3415529B1 (en) | 2007-09-26 | 2020-11-04 | Chugai Seiyaku Kabushiki Kaisha | Modified antibody constant region |
| EP2275443B1 (en) | 2008-04-11 | 2015-12-02 | Chugai Seiyaku Kabushiki Kaisha | Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly |
| TWI440469B (zh) * | 2008-09-26 | 2014-06-11 | Chugai Pharmaceutical Co Ltd | Improved antibody molecules |
| TWI682995B (zh) | 2009-03-19 | 2020-01-21 | 日商中外製藥股份有限公司 | 抗體恆定區域改變體 |
| WO2010107110A1 (ja) | 2009-03-19 | 2010-09-23 | 中外製薬株式会社 | 抗体定常領域改変体 |
| TWI654204B (zh) | 2010-11-30 | 2019-03-21 | Chugai Seiyaku Kabushiki Kaisha | 具有鈣依存性的抗原結合能力之抗體 |
| MY163081A (en) * | 2010-12-28 | 2017-08-15 | Chugai Pharmaceutical Co Ltd | Animal cell culturing method |
| WO2013164694A1 (en) | 2012-04-30 | 2013-11-07 | Biocon Limited | Targeted/immunomodulatory fusion proteins and methods for making same |
| PL2970512T3 (pl) * | 2013-03-12 | 2019-03-29 | Biocon Limited | Immunomodulujące białka fuzyjne i sposoby ich otrzymywania |
| WO2014200018A1 (ja) | 2013-06-11 | 2014-12-18 | 独立行政法人 国立精神・神経医療研究センター | 再発寛解型多発性硬化症（ｒｒｍｓ）患者の治療予後予測方法、及び新規治療適応判断方法 |
| TWI873632B (zh) | 2015-02-27 | 2025-02-21 | 日商中外製藥股份有限公司 | Il-6受體抗體用於製備醫藥組成物的用途 |
| PL3299810T3 (pl) | 2015-05-19 | 2021-12-13 | National Center Of Neurology And Psychiatry | Sposób określania zastosowania nowej terapii u pacjentów ze stwardnieniem rozsianym (sm) |
| PT3500586T (pt) * | 2016-10-17 | 2021-06-17 | Enzene Biosciences Ltd | Processo contínuo para reduzir a heterogeneidade da proteína terapêutica |
| US11851486B2 (en) | 2017-05-02 | 2023-12-26 | National Center Of Neurology And Psychiatry | Method for predicting and evaluating therapeutic effect in diseases related to IL-6 and neutrophils |
| US11692037B2 (en) | 2017-10-20 | 2023-07-04 | Hyogo College Of Medicine | Anti-IL-6 receptor antibody-containing medicinal composition for preventing post-surgical adhesion |
| WO2019151418A1 (ja) | 2018-01-31 | 2019-08-08 | 元一 加藤 | Ｉｌ－６阻害剤を含有する喘息の治療剤 |
| WO2020213665A1 (ja) | 2019-04-17 | 2020-10-22 | 国立大学法人広島大学 | Ｉｌ－６阻害剤及びｃｃｒ２阻害剤を組み合わせて投与することを特徴とする泌尿器がんの治療剤 |
| TWI872251B (zh) | 2020-05-29 | 2025-02-11 | 日商中外製藥股份有限公司 | 含有抗體製劑 |
-
1989
- 1989-09-26 BG BG089846A patent/BG60017B2/bg unknown
- 1989-09-26 NZ NZ230786A patent/NZ230786A/xx unknown
- 1989-09-26 IL IL9177889A patent/IL91778A/en not_active IP Right Cessation
- 1989-09-26 RO RO141765A patent/RO105652B1/ro unknown
- 1989-09-26 AR AR89310004A patent/AR242986A1/es active
- 1989-09-26 CA CA000613379A patent/CA1332367C/en not_active Expired - Fee Related
- 1989-09-27 DK DK475389A patent/DK475389A/da not_active Application Discontinuation
- 1989-09-27 IE IE309489A patent/IE63562B1/en not_active IP Right Cessation
- 1989-09-27 DE DE68913251T patent/DE68913251T2/de not_active Expired - Fee Related
- 1989-09-27 ES ES89309851T patent/ES2049332T3/es not_active Expired - Lifetime
- 1989-09-27 EP EP89309851A patent/EP0361902B1/en not_active Expired - Lifetime
- 1989-09-27 PL PL89281598A patent/PL162260B1/pl unknown
- 1989-09-27 MX MX017721A patent/MX170441B/es unknown
- 1989-09-27 AU AU42343/89A patent/AU615576B2/en not_active Ceased
- 1989-09-27 AT AT89309851T patent/ATE101876T1/de not_active IP Right Cessation
- 1989-09-28 JP JP1256890A patent/JP2925181B2/ja not_active Expired - Fee Related
- 1989-09-28 CN CN89107508.9A patent/CN1041392A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| BG60017B2 (bg) | 1993-06-30 |
| AU615576B2 (en) | 1991-10-03 |
| EP0361902A2 (en) | 1990-04-04 |
| AR242986A1 (es) | 1993-06-30 |
| DE68913251D1 (de) | 1994-03-31 |
| IE893094L (en) | 1990-03-28 |
| EP0361902B1 (en) | 1994-02-23 |
| CN1041392A (zh) | 1990-04-18 |
| ATE101876T1 (de) | 1994-03-15 |
| DK475389A (da) | 1990-03-29 |
| AU4234389A (en) | 1990-04-05 |
| EP0361902A3 (en) | 1990-08-16 |
| JPH02163096A (ja) | 1990-06-22 |
| MX170441B (es) | 1993-08-23 |
| JP2925181B2 (ja) | 1999-07-28 |
| RO105652B1 (ro) | 1992-11-30 |
| CA1332367C (en) | 1994-10-11 |
| IL91778A (en) | 1994-10-07 |
| ES2049332T3 (es) | 1994-04-16 |
| NZ230786A (en) | 1991-11-26 |
| DE68913251T2 (de) | 1994-06-23 |
| PL162260B1 (pl) | 1993-09-30 |
| IE63562B1 (en) | 1995-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK475389A (da) | Fremgangsmaade til reduktion af monoklonale antistoffers heterogenitet | |
| FI925631A7 (fi) | Monoklonaaliset vasta-aineet | |
| DK65185D0 (da) | Fremgangsmaade til fremstilling af antistof | |
| DK98584A (da) | Fremgangsmaade til detektering af aendret dna | |
| DK610587A (da) | Analysemetode og -saet for antistof til hepatitis b-kerneantigen | |
| DK188185A (da) | Monoklonalt antistof | |
| DK14589D0 (da) | Fremgangsmaade til fremstilling af 1-alkyl-5-nitroimidazoler | |
| DK319685D0 (da) | Monoklonale antistoffer, fremgangsmaade til frembringelse af antistofferne, hybridomaceller, der producerer antistofferne, og anvendelse af antistofferne | |
| DK409388D0 (da) | Fremgangsmaade til reduktion af ketoner | |
| DK388787A (da) | Fremgangsmaade til fremstilling af interferon | |
| DK147885D0 (da) | Fremgangsmaade til fremstilling af glycosidbindingrelateret antigen | |
| DK437087D0 (da) | Monoklont antistof til bestemmelse af humant glycoalbumin | |
| DK144485A (da) | Monoklonale antistoffer | |
| DK355584D0 (da) | Fremgangsmaade til fremstilling af 3-exomethylen-cephalosporiner | |
| DK717888D0 (da) | Monoklonale antistoffer | |
| DK0401657T3 (da) | Fremgangsmåde til C-terminal modificering af proteiner | |
| DK276185D0 (da) | Monoklonale antistoffer,fremgangsmaade til fremstilling af disse samt deres diagnostiske anvendelse | |
| DK161570C (da) | Fremgangsmaade og apparat til korrugering af metalroer | |
| DK329685D0 (da) | Fremgangsmaade til fremstilling af alfa-l-aspartyl-l-phenylalaninalkylestere | |
| DK413389D0 (da) | Monoklonale antistoffer | |
| DK338889A (da) | Fremgangsmaade til bestemmelse af antistoffer | |
| DK240286A (da) | Monoklonale antistoffer | |
| DK143389D0 (da) | Fremgangsmaade til fremstilling af 20-deoxotylosin | |
| DK49585D0 (da) | Fremgangsmaade til paavirkning af laeskehastigheden for braendt kalk og anvendelse af fremgangsmaaden | |
| DK630886A (da) | Monoklonalt antistof mod human pancreas-amylase, fremgangsmaade til fremstilling deraf og fremgangsmaade til bestemmelse af human pancreas-amylase ved hjaelp af antistoffet |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHS | Application shelved for other reasons than non-payment |